Central adjudication of serious adverse events did not affect trial’s safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

BACKGROUND AND PURPOSE: Central adjudication of serious adverse events (SAEs) can be undertaken in clinical trials, especially for open-label studies where outcome assessment may be at risk of bias. This study explored the effect of central adjudication of SAEs on the safety results of the Efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Godolphin, Peter J., Montgomery, Alan A., Woodhouse, Lisa J., Bereczki, Daniel, Berge, Eivind, Collins, Rónán, Díez-Tejedor, Exuperio, Gommans, John, Lees, Kennedy R., Ozturk, Serefnur, Phillips, Stephen, Pocock, Stuart, Prasad, Kameshwar, Szatmari, Szabolcs, Wang, Yongjun, Bath, Philip M., Sprigg, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258247/
https://www.ncbi.nlm.nih.gov/pubmed/30475912
http://dx.doi.org/10.1371/journal.pone.0208142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258247/
https://www.ncbi.nlm.nih.gov/pubmed/30475912
http://dx.doi.org/10.1371/journal.pone.0208142

Ejemplares similares